PATENT CLAIM ANALYSIS

Application Number: 15950512
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "200000"]

Abstract:
The invention relates to the field of medicine. Among others, it relates to biologically active analogs of interferons (IFNs) which show less unwanted side-effects and to the therapeutic uses thereof. Provided is an IFN analog, wherein the moiety mediating binding to its natural receptor is at least functionally disrupted and wherein the analog comprises a signaling moiety capable of mediating intracellular IFN activity, said signaling moiety being provided at its N-terminus, optionally via a linker, with at least one targeting domain capable of binding to a cell surface receptor other than the IFN receptor.

Claim (Index 17):
A conjugate comprising a compound of interest conjugated to a targeting domain, said targeting domain comprising the amino acid sequence X 1 SRNLIDX 2  (SEQ ID NO: 21)-linker-X 3 SRNLIDX 4 (SEQ ID NO: 21), wherein the pair of X 1  and X 2  and the pair of X 3  and X 4  can form a bond, preferably a peptidic bond, such that a bicyclic structure is formed wherein the sequences SRNLID are each part of a ring, and wherein the linker is an amino acid sequence of 2 to 7 amino acid residues.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.57576
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13519808', '10540959', '14103564', '13130007', '15570910']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7402199823804078
- 35 USC 102 Novelty (BERT): 0.5611145890157347
- Combined Prediction Score: 0.7223094430439404
- Mean Citation Score: 243.614762
- Max Citation Score: 476.17416
- Similarity Product: 320.1649156476116

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test